Carnitine and left ventricular function in haemodialysis patients.

Area of Science:

• Cardiology
• Nephrology
• Biochemistry

Background:

• Hemodialysis patients often exhibit cardiac dysfunction.
• Carnitine deficiency has been hypothesized as a contributing factor to this dysfunction.

Purpose of the Study:

• To investigate the effect of L-carnitine supplementation on left ventricular function in hemodialysis patients.
• To determine if carnitine depletion is responsible for cardiac dysfunction in this population.

Main Methods:

• A double-blind, placebo-controlled study over six weeks.
• Non-invasive assessment of left ventricular function before and after L-carnitine or saline administration.
• Measurement of muscle and plasma carnitine concentrations.

Main Results:

• L-carnitine administration significantly increased muscle and plasma carnitine levels.
• No significant improvements were observed in any cardiac function tests after L-carnitine supplementation.
• No correlation was found between cardiac function variables and carnitine concentrations.

Conclusions:

• Carnitine depletion does not appear to be the primary cause of cardiac dysfunction in hemodialysis patients.
• L-carnitine supplementation, at the studied dosage and duration, did not improve cardiac function in this cohort.